Stock market anomaly | China Stone Pharmaceutical Group (01093.HK) rose nearly 3% and agreed to grant Cipla exclusive license in the U.S. to sell Eliquis lipid emulsion injections

According to the Wise Finance APP, China Medicine Group (01093.HK) has risen by nearly 3%. As of the time of publication, it has risen by 5.86%, trading at 5.87 Hong Kong dollars, with a transaction amount of 170 million Hong Kong dollars.